Literature DB >> 850690

Influences of genotype and sex on behavioral tolerance to nicotine in mice.

P C Hatchell, A C Collins.   

Abstract

Spontaneous motor activity in a Y-maze was measured in DBA/2Ibg and C57BL/6Ibg mice which had received nicotine or saline injections three times a day for two, four or seven days. Both genotype and sex influenced the development of tolerance to nocotine's effects on spontaneous motor activity, with DBA males requiring the longest exposure to nicotine and C57 males requiring the shortest drug exposure for tolerance development. DBA and C57 females developed behavioral tolerance equally after two days of pretreatment, but the C57 females showed a greater degree of tolerance after seven days of injections than did the DBA females. The development of behavioral tolerance in DBA males after four days of nicotine pretreatment was associated with the development of behavioral tolerance in DBA males after four days of nicotine pretreatment was associated with the development of drug dispositional tolerance, with minimal evidence for a change in nervous system sensitivity. Drug dispositional tolerance in DBA females, C57 males and C57 females, however, did not seem to affect spontaneous motor activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850690     DOI: 10.1016/0091-3057(77)90156-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Effects of chronic administration of tobacco smoke to mice: behavioral and metabolic measures.

Authors:  D S Baer; G E McClearn; J R Wilson
Journal:  Psychopharmacology (Berl)       Date:  1980-02       Impact factor: 4.530

2.  The development of pharmacological tolerance to the effect of nicotine on schedule-controlled responding in mice.

Authors:  J S Hendry; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice.

Authors:  Kia J Jackson; Carrie L Walters; Michael F Miles; Billy R Martin; M Imad Damaj
Journal:  Neuropharmacology       Date:  2009-07-18       Impact factor: 5.250

4.  The effect of chronic nicotine treatment on nicotine-induced seizures.

Authors:  L L Miner; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Nicotine-produced relearning deficit in C57BL/6J and DBA/2J mice.

Authors:  D M Gilliam; K Schlesinger
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 6.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

7.  Adrenalectomy reverses chronic injection-induced tolerance to nicotine.

Authors:  E A Grun; J R Pauly; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Tolerance to nicotine following chronic treatment by injections: a potential role for corticosterone.

Authors:  J R Pauly; E U Grun; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 9.  Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction.

Authors:  Yann S Mineur; Marina R Picciotto
Journal:  Biochem Pharmacol       Date:  2007-06-14       Impact factor: 5.858

10.  An analysis of response to nicotine infusion using an automated radiotelemetry system.

Authors:  S F Robinson; J R Pauly; M J Marks; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.